KALV
KalVista Pharmaceuticals Inc.
$11.50
-$0.31(-2.62%)
31
Overall
40
Value
25
Tech
28
Quality
Market Cap
$NaN
Volume
1.15M
52W Range
$7.30 - $17.28
Target Price
$31.67
EPS Estimates Overview
| Current Quarter | $-1 | Next Quarter | $-0.86 |
| Current Year | $-3.42 | Next Year | $-2.28 |
| QoQ Growth | +14.0% | YoY Growth | +33.3% |
| 3Y EPS CAGR | -3.2% | Target Price | $31.67 |
| Consensus | Buy | Upside | +175.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $11.50 | -2.6% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW